Itk is required for Th9 differentiation via TCR-mediated induction of IL-2 and IRF4.
Itk is required for Th9 differentiation via TCR-mediated induction of IL-2 and IRF4.
复制标题
DOI:
10.1038/ncomms10857
复制
发表时间:
2016-03-03
影响因子:
16.6
通讯作者:
Schwartzberg PL
中科院分区:
文献类型:
--
作者:
Gomez-Rodriguez J;Meylan F;Handon R;Hayes ET;Anderson SM;Kirby MR;Siegel RM;Schwartzberg PL
Th9 cells produce interleukin (IL)-9, a cytokine implicated in allergic asthma and autoimmunity. Here we show that Itk, a mediator of T cell receptor signalling required for Th2 immune responses and the development of asthma, is a positive regulator of Th9 differentiation. In a model of allergic lung disease, Itk-deficient mice show reduced pulmonary inflammation and IL-9 production by T cells and innate lymphoid type 2 cells (ILC2), despite normal early induction of ILC2s. In vitro, Itk−/− CD4+ T cells do not produce IL-9 and have reduced levels of IRF4 (Interferon Regulator Factor 4), a critical transcription factor for effector T cell function. Both IL-9 and IRF4 expression are rescued by either IL-2 or constitutively active STAT5, but not NFATc1. STAT5 binds the Irf4 promoter, demonstrating one mechanism by which IL-2 rescues weakly activated T cells. Itk inhibition also reduces IL-9 expression by human T cells, implicating ITK as a key regulator of Th9 induction. The Tec family tyrosine kinase, Itk, is a component of the T-cell receptor essential for optimal Th2 responses in vivo. Here the authors show in human cells and mouse models that Itk is also needed for the production of IL-9, an important contributor to allergic asthma.